CLV IntelligenceReimbursement Policy Monitoring

Code intelligence

LCD-L40238 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code LCD-L40238.

Critical code risk

Signal breakdown

1 shown · 1 total in platform

Risk: Critical
1

Critical

100%

0

High

0%

0

Routine

0%

0

Low

0%

New this month

+1

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

LCD L40238: MolDX: Genetic Testing for Hereditary Thrombophilia — Palmetto GBA

Policy LCD-L40238 · Clinical Laboratory

Critical

This final LCD from Palmetto GBA establishes coverage criteria for genetic testing related to hereditary thrombophilia, effective October 12, 2026, across seven southeastern states under Part A and Pa

View alert

Audit documentation

Building an audit file that includes LCD-L40238?

The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription